Study for Novel Coronavirus Pneumonia (NCP)

Huazhong University of Science and Technology

Status: Unknown

Conditions: Novel Coronavirus Pneumonia

Treatments: Combination Product: systemic treatment

Study type: Observational

Funder types: Other

Identifiers

NCT04283396

NCP01

Details and patient eligibility

About

To develop practical and effective clinical diagnosis and treatment schemes for the control of novel coronavirus pneumonia.

Full description

By retrospectively analyzing the clinical epidemiological characteristics of the novel coronavirus pneumonia and the current diagnosis and treatment schemes, as well as in-depth analyzing the disease development process and outcome trends of NCP patients to develop practical and effective clinical diagnosis and treatment schemes and provide guarantee for the rapid control of the epidemic.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18 to 90 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients confirmed with novel coronavirus pneumonia. The Diagnostic criteria refer to "Pneumonitis Diagnosis and Treatment Scheme for Novel Coronavirus Infection (Trial Version 5)";

Exclusion criteria

• Physician judged the patient was not suitable for this clinical trial.